Advantagene Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Advantagene Inc (Advantagene) is a biopharmaceutical company. It manufactures, develops, and tests cancer immunotherapy drugs and gene-based biologics. It offers a proprietary Gene Mediated Cytotoxic Immunotherapy (GMCI), a platform technology designed to stimulate a patients immune system which enables them to naturally fight against cancer. GMCI technology can be applied to a variety of solid tumors and is based on a relatively low cost and readily available viral vector product (aglatimagene besadenovec; a.k.a. AdV-tk) that generates a powerful patient-specific anti-tumor immune response. GMCI can be used in the treatment of prostate cancer, adult and pediatric brain cancer, pancreatic cancer, malignant pleural effusion and mesothelioma.

Advantagene Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 4
List of Figures 4
Advantagene Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Advantagene Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Advantagene Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Advantagene Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Advantagene Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Advantagene Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Advantagene Raises USD5 Million in Venture Financing 10
Partnerships 11
Advantagene Enters into Agreement with Bristol-Myers Squibb 11
Equity Offering 12
Advantagene Raises USD14.2 Million in Private Placement of Series A Preferred Stock 12
Advantagene Inc - Key Competitors 13
Advantagene Inc - Key Employees 14
Advantagene Inc - Locations And Subsidiaries 15
Head Office 15
Recent Developments 16
Corporate Communications 16
Oct 04, 2017: Advantagene Names Edward J. Benz Jr., M.D., As Board Director 16
Jan 25, 2017: Gregory J. Gailius Joins Advantagene Board of Directors as Chairman of Audit Committee 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List Of Tables


Advantagene Inc, Pharmaceuticals & Healthcare, Key Facts 2
Advantagene Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Advantagene Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Advantagene Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Advantagene Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Advantagene Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Advantagene Raises USD5 Million in Venture Financing 10
Advantagene Enters into Agreement with Bristol-Myers Squibb 11
Advantagene Raises USD14.2 Million in Private Placement of Series A Preferred Stock 12
Advantagene Inc, Key Competitors 13
Advantagene Inc, Key Employees 14

List Of Figures


Advantagene Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Advantagene Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Advantagene Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Advantagene Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Advantagene Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Advantagene Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Advantagene Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Advantagene Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Advantagene Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Advantagene Inc (Advantagene) is a biopharmaceutical company. It manufactures, develops, and tests cancer immunotherapy drugs and gene-based biologics. It offers a proprietary Gene Mediated Cytotoxic Immunotherapy (GMCI), a platform technology

USD 250 View Report

Advantagene, Inc Company Profile- Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis

Advantagene, Inc Company Profile is a complete analysis of the companys operations, strategies, outlook and historic performance. The research work analyzes key strategies in current market conditions, SWOT profile, future

USD 200 View Report

Metabolomic Technologies Inc - Product Pipeline Analysis, 2018 Update

Metabolomic Technologies Inc (MTI) is a diagnostic company that develops metabolomic-based diagnostic systems. The companys products comprise ColoDx, PolypDx, BreastDx, ProstateDx, CeliacDx, ColitisDx, CrohnsDx and other products. Its products develop

USD 750 View Report

Xhale Inc - Product Pipeline Analysis, 2018 Update

Xhale Inc (Xhale) is a medical technology company that develops and commercializes patient-centric monitoring solutions for the healthcare industry. The company offers platforms such as SMART and assurance platforms. Its

USD 750 View Report

Your are not allow to send sample request

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available